Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

4.405 -0.265 (-5.67%)
Streaming Delayed Price Updated: 10:33 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Is It Too Late to Buy Hims & Hers Health Stock?
Shares are up 248% from their low. 
Via The Motley Fool
GoodRx Holdings Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Analyst Expectations for GoodRx Holdings's Future
 
Via Benzinga
Why GoodRx Stock Rallied Wednesday Morning
The prescription drug discount and digital health specialist delivered results that weren't as bad as investors had feared. 
Via The Motley Fool
GoodRx (GDRX) Q4 2022 Earnings Call Transcript
GDRX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Shares Of Goodrx Are Looking Good After Earnings Beat: Here's What You Need To Know
Shares of Goodrx Holdings Inc (NASDAQ: GDRX) are trading higher into Tuesday’s after-hours session following the company’s fourth-quarter earnings report. Here’s what investors need to know. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Barclays Maintains Overweight Rating for GoodRx Holdings: Here's What You Need To Know
 
Via Benzinga
The Latest Analyst Ratings for GoodRx Holdings
 
Via Benzinga
GoodRx Holdings's Return on Invested Capital Overview
 
Via Benzinga
GoodRx Reports Fourth Quarter and Full Year 2022 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx to Present at the Cowen 43rd Annual Health Care Conference
From GoodRx Holdings, Inc.
Via Business Wire
2 Healthcare Companies That Could Be Acquired Within 5 Years
These stocks are also cheap buys that are down more than 60% from their highs. 
Via The Motley Fool
GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
Expert Ratings for GoodRx Holdings
 
Via Benzinga
7 Sorry Tech Stocks to Sell in February Before It’s Too Late
Here are seven sorry tech stocks to sell in February before it's too late. These companies' businesses are troubled are struggling. 
Via InvestorPlace
Is Amazon the Future of Healthcare?
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit? 
Via The Motley Fool
These 2 FAANG Stocks Were in the Spotlight Tuesday
Big news could affect both businesses significantly, and both stocks contributed to a lower close for the Nasdaq. 
Via The Motley Fool
Amazon's Discount Drug Plan: Game Changer, or a Day Late and a Dollar Short?
The e-commerce giant has designs on the healthcare industry. 
Via The Motley Fool
Where to Invest $500 in 2023: 3 Stocks That Could Be Winners
These investments could make the most of your money next year, whether your focus is on growth or dividends. 
Via The Motley Fool
GoodRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
From GoodRx Holdings, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Shares of GoodRx Holdings Fell 18.7% Lower This Week
The company, which focuses on delivering prescription drug discounts, has struggled this year. 
Via The Motley Fool
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. 
Via Benzinga
2 Growth Stocks Down More Than 50% From Their Highs That Could Be Hot Buys for 2023
These businesses could perform much better next year. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
 
Via Benzinga
Can Doximity Stock Keep On Climbing?
A positive earnings report recently pushed Doximity through the roof, but Investors want to know whether the stock can deliver long-term gains. 
Via The Motley Fool
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.